Latest immunotherapy news
.jpg)
FDA Approves Imfinzi for Early Gastric and Gastroesophageal Cancers
posted December 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Early Use of Higher-Efficacy Therapies Recommended for Moderate-to-Severe Crohn Disease
posted November 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Darzalex Faspro for High-Risk Smoldering Multiple Myeloma
posted November 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis Related Articles
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors Monthly Specialist Briefings
Stay Connected
